Clinical Trials Logo

Liver Cancer clinical trials

View clinical trials related to Liver Cancer.

Filter by:

NCT ID: NCT00717756 Completed - Liver Cancer Clinical Trials

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Start date: January 2009
Phase: Phase 2
Study type: Interventional

This study will determine whether lenalidomide has activity in patients with advanced liver cancer that have had growth of their cancer after sorafenib.

NCT ID: NCT00716976 Completed - Ovarian Cancer Clinical Trials

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Start date: June 23, 2008
Phase: Phase 3
Study type: Interventional

RATIONALE: Sodium thiosulfate may reduce or prevent hearing loss in young patients receiving cisplatin for cancer. It is not yet known whether sodium thiosulfate is more effective than no additional treatment in preventing hearing loss. PURPOSE: This randomized phase III trial is studying sodium thiosulfate to see how well it works in preventing hearing loss in young patients receiving cisplatin for newly diagnosed germ cell tumor, hepatoblastoma, medulloblastoma, neuroblastoma, osteosarcoma, or other malignancy.

NCT ID: NCT00666978 Completed - Lung Cancer Clinical Trials

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Start date: December 2007
Phase: Phase 4
Study type: Interventional

RATIONALE: A stop-smoking plan that includes health education counseling and bupropion may help African-American smokers stop smoking. It is not yet known whether health education counseling is more effective with or without bupropion in helping African Americans stop smoking. PURPOSE: This clinical trial is studying health education counseling and bupropion to see how well they work compared with a placebo and health education counseling in helping African Americans smokers stop smoking.

NCT ID: NCT00654160 Completed - Colorectal Cancer Clinical Trials

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Start date: June 2008
Phase: Phase 1
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of irinotecan when given together with fluorouracil and leucovorin in treating patients with advanced gastrointestinal cancer.

NCT ID: NCT00652132 Completed - Liver Cancer Clinical Trials

Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer

SIOPEL6
Start date: December 15, 2007
Phase: Phase 3
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Chemoprotective drugs, such as sodium thiosulfate, may protect normal cells from the side effects of chemotherapy. It is not yet known whether giving sodium thiosulfate is effective in reducing hearing damage caused by cisplatin in treating young patients with liver cancer. PURPOSE: This randomized phase III trial is studying how well sodium thiosulfate works to decrease hearing loss caused by cisplatin in treating young patients with stage I, stage II, or stage III childhood liver cancer.

NCT ID: NCT00614913 Completed - Clinical trials for Hepatocellular Carcinoma

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

Start date: May 1998
Phase: Phase 1/Phase 2
Study type: Interventional

This study is designed to evaluate the possible benefits and side effects of the use of proton therapy for patients with hepatocellular carcinoma.

NCT ID: NCT00607828 Completed - Liver Cancer Clinical Trials

Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer

Start date: November 16, 2007
Phase: N/A
Study type: Interventional

RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I trial is studying the side effects and best dose of stereotactic radiation therapy in treating patients with advanced liver cancer.

NCT ID: NCT00605722 Completed - Liver Cancer Clinical Trials

A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

Start date: March 2008
Phase: Phase 2
Study type: Interventional

This single arm study evaluated the efficacy and safety of a combination of Tarceva and Avastin in patients with advanced or metastatic liver cancer. Patients were treated with Tarceva 150 mg po daily plus Avastin 5 mg/kg intravenous (iv) every 2 weeks. The anticipated time on study treatment was until disease progression, and the target sample size was <100 individuals.

NCT ID: NCT00581815 Completed - Breast Cancer Clinical Trials

Spectroscopy With Surface Coils and Decoupling

Start date: February 1997
Phase: Phase 1
Study type: Interventional

The purpose of this study is to obtain chemical information from part of your body without a biopsy. This is done using a technique called magnetic resonance spectroscopy (MRS) which is similar to magnetic resonance imaging (MRI) except that signals are detected from the chemicals (spectroscopy) naturally present in your body using radio waves. To receive this information from your body, small loops of wire (surface coils), placed near the tissue of interest, may be used to more effectively detect signals that come from the chemicals in your body. The investigators may use a second radio channel simultaneously, which will allow us to obtain greater chemical information (decoupling). The results may also help us to understand how this study can be used to help other patients with your condition.

NCT ID: NCT00579865 Completed - Liver Cancer Clinical Trials

Quality Of Life in Patients With Malignant Biliary Obstruction

Start date: May 2005
Phase: N/A
Study type: Observational

You may have symptoms like itching, abdominal pain, loss of appetite, fatigue, fevers and chills. The treatment you will receive to relieve the blockage is also intended to relieve symptoms and improve your quality of life. The purpose of this study is to find out if relieving the blockage in your bile duct improves your quality of life.